Pyridostigmine for treatment of neurogenic orthostatic hypotension [correction of hypertension]--a follow-up survey study.

Abstract

We report the result of a follow-up, open-label study of pyridostigmine for treatment of orthostatic hypotension. Aim of the study was to evaluate self-reported efficacy and patients' satisfaction with the medication. Most patients were very satisfied with the medication and chose to continue it.

• Authors: Paola Sandroni, Tonette L Opfer-Gehrking, Wolfgang Singer, Phillip A Low
• Journal: Clinical autonomic research : official journal of the Clinical Autonomic Research Society (Clin Auton Res) Vol. 15 Issue 1 Pg. 51-3 (Feb 2005) ISSN: 0959-9851 [Print] Germany
• PMID: 15768203 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S.)

Chemical References

• Cholinesterase Inhibitors
• Pyridostigmine Bromide

Topics

• Aged
• Autonomic Nervous System Diseases (complications, drug therapy)
• Cholinesterase Inhibitors (administration & dosage)
• Female
• Follow-Up Studies
• Humans
• Hypotension, Orthostatic (drug therapy, etiology)
• Male
• Middle Aged
• Pyridostigmine Bromide (administration & dosage)
• Treatment Outcome